Arcadia Biosciences, Inc. (NASDAQ:RKDA) Files An 8-K Results of Operations and Financial Condition

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Files An 8-K Results of Operations and Financial Condition
Item 2.02.

Story continues below

Results of Operations and Financial Condition.

On August 10, 2017, Arcadia Biosciences, Inc. (the “Company”) issued a press release announcing financial results for the second quarter ended June 30, 2017. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished in this Form 8-K and the press release attached as Exhibit 99.1, shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 2.02 and in the press release attached as Exhibit 99.1 shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 2.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 7, 2017, the Board of Directors (the “Board”) of the Company, upon the recommendation of its Nominating and Governance Committee, appointed Amy Yoder to serve as a Class III director of the Company, effective immediately. Ms. Yoder was appointed to serve as a Class III director and will stand for re-election at the Company’s 2018 Annual Meeting of Stockholders.

Ms. Yoder, age 50, is currently the president and CEO of Anuvia Plant Nutrients, a company that creates enhanced plant nutrition products from recycled organic waste sources. She previously served as the president and CEO of Arysta LifeScience and has held a variety of senior sales, marketing and executive positions with companies throughout the agricultural and related industries, including Spectrum Brands, BioLab and United Agri Products. Yoder received a bachelor’s degree in agricultural technology and systems management from Michigan State University, with an emphasis in crop and soil science.

Ms. Yoder has (i)no arrangements or understandings with any other person to which he was appointed to as a director of the Company, and (ii)no family relationship with any director or executive officer of the Company or any person nominated or chosen by the Company to become a director or executive officer. Ms. Yoder does not have any relationship or related transaction with the Company that would require disclosure to Item 404(a) of Regulation S-K under the Securities Act of 1933, as amended.

In connection with her service as a new director, Ms. Yoder will receive the standard compensation paid by the Company to all of its non-employee directors, including an initial option grant, an annual cash retainer and an annual option grant upon the date of the Company’s Annual Meeting of Stockholders. This standard non-employee director compensation, a portion of which will be pro-rated to reflect the actual time Ms. Yoder will serve on the Company’s Board this year, is described under the heading of “Non-Employee Director Compensation Policy” in the Company’s Proxy Statement for its Annual Meeting of Stockholders filed with the Securities and Exchange Commission (“SEC”) on April 26, 2017. In connection with her appointment, Ms. Yoder will enter into a standard indemnification agreement with the Company in the form previously approved by the Board, which was filed as Exhibit 10.7 to the Company’s Registration Statement on Form S-1 filed with the SEC on February 17, 2015 and incorporated by reference herein.

The Company issued a press release on August 9, 2017 announcing the appointment of Ms. Yoder to the Company’s Board.

Item 2.02.

Financial Statements and Exhibits.

Arcadia Biosciences, Inc. Exhibit
EX-99.1 2 rkda-ex991_6.htm EX-99.1 rkda-ex991_6.htm Exhibit 99.1 FOR IMMEDIATE RELEASE       Media Contact:    Jeff Bergau [email protected] +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES SECOND-QUARTER AND FIRST-HALF 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS   — Revenues Up,…
To view the full exhibit click here

About Arcadia Biosciences, Inc. (NASDAQ:RKDA)

Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market. Its crop yield traits are utilized by its partners to develop higher yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf and trees. The Company’s portfolio of agricultural productivity traits includes Nitrogen Use Efficiency (NUE), Water Use Efficiency (WUE), Drought Tolerance (DT), Salinity Tolerance (ST) and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada.

An ad to help with our costs